The Independence Investment Fund Act aims to establish a fund that invests in companies developing critical and emerging technologies, particularly in biotechnology, to enhance the national and economic security of the United States. The primary objective is to support innovation and ensure that the U.S. remains competitive against foreign adversaries. Key provisions of the Act include the creation of the Independence Investment Fund within the Department of the Treasury, which will focus on U.S.-based companies working on technologies vital for national security.